Stockreport

ALX Oncology Highlights $150M Raise, Evorpacept Breast Cancer Push and EGFR ADC ALX2004 Update [Yahoo! Finance]

ALX Oncology Holdings Inc.  (ALXO) 
PDF 2028 and will fund a concentrated effort to make both lead programs pivotal-ready by the end of next year. Clinical data highlight evorpacept's potential as a CD47 -ta [Read more]